SynBiotic SE (XTER:SBX) EPS (Basic) : €-5.37 (TTM As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is SynBiotic SE EPS (Basic)?

SynBiotic SE's basic earnings per share (Basic EPS) for the six months ended in Dec. 2023 was €0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Dec. 2023 was €-5.37.

SynBiotic SE's EPS (Diluted) for the six months ended in Dec. 2023 was €0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €-5.37.

SynBiotic SE's EPS without NRI for the six months ended in Dec. 2023 was €0.00. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was -5.15.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

SynBiotic SE EPS (Basic) Historical Data

The historical data trend for SynBiotic SE's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SynBiotic SE EPS (Basic) Chart

SynBiotic SE Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

-0.05

-0.55

-4.09

-5.97

-2.24

SynBiotic SE Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Dec23
EPS (Basic)	Get a 7-Day Free Trial				-0.16	-3.30	-0.34	-5.03	-

SynBiotic SE EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

SynBiotic SE's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-10.631	-	0)	/	4.749
	=	-2.24

SynBiotic SE's Basic EPS for the quarter that ended in Dec. 2023 is calculated as

Basic EPS (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(0	-	0)	/	4.749
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-5.37

SynBiotic SE (XTER:SBX) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

SynBiotic SE EPS (Basic) Related Terms

Thank you for viewing the detailed overview of SynBiotic SE's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

SynBiotic SE Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » SynBiotic SE (XTER:SBX) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

N/A

Address

Barer Strasse 7, Munich, BY, DEU, 80333

Website

https://www.synbiotic.com

SynBiotic SE is engaged in the development of Phyto-cannabinoids and other herbal compounds concentrated molecules as well as the development of wellness products. The company engages in synthetic production, drug development, cannabinoids, dietary supplements and cosmetic products. Geographical presence in Germany, Austria, UK, Switzerland and Other countries. Majority of its revenue comes from domestic market.

Executives

Daniel Kruse

Geschäftsführender Direktor

SynBiotic SE Headlines

No Headlines